Nonoperating Income (Expense) of Item 9 Labs Corp. from 31 Dec 2011 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Item 9 Labs Corp. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2011 to 30 Jun 2023.
  • Item 9 Labs Corp. Nonoperating Income (Expense) for the quarter ending 30 Jun 2023 was $2,950,462, a 82% decline year-over-year.
  • Item 9 Labs Corp. Nonoperating Income (Expense) for the twelve months ending 30 Jun 2023 was $10,884,138, a 46% decline year-over-year.
  • Item 9 Labs Corp. annual Nonoperating Income (Expense) for 2022 was $8,100,598, a 53% decline from 2021.
  • Item 9 Labs Corp. annual Nonoperating Income (Expense) for 2021 was $5,304,509, a 24% increase from 2020.
  • Item 9 Labs Corp. annual Nonoperating Income (Expense) for 2020 was $6,959,691, a 1601% decline from 2019.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Item 9 Labs Corp. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $10,884,138 $2,950,462 -$1,325,307 -82% 01 Apr 2023 30 Jun 2023 10-Q 21 Aug 2023 2023 Q3
Q1 2023 $9,558,831 $2,107,310 -$1,010,255 -92% 01 Jan 2023 31 Mar 2023 10-Q 22 May 2023 2023 Q2
Q4 2022 $8,548,576 $1,658,368 -$447,978 -37% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2023 2023 Q1
Q3 2022 $8,100,598 $4,167,998 -$626,874 -18% 01 Jul 2022 30 Sep 2022 10-K 13 Jan 2023 2022 FY
Q2 2022 $7,473,724 $1,625,155 -$1,038,524 -177% 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023 2023 Q3
Q1 2022 $6,435,200 $1,097,055 -$628,668 -134% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023 2023 Q2
Q4 2021 $5,806,532 $1,210,390 -$502,023 -71% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q1
Q3 2021 $5,304,509 $3,541,124 01 Jul 2021 30 Sep 2021 10-K 13 Jan 2023 2022 FY
Q2 2021 $586,631 +$777,208 +57% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q3
Q1 2021 $468,387 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q2
Q4 2020 $708,367 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q1
Q2 2020 $1,363,839 -$1,471,735 -1364% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q3
Q2 2019 $107,896 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q3

Item 9 Labs Corp. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $8,100,598 -$2,796,089 -53% 01 Oct 2021 30 Sep 2022 10-K 13 Jan 2023 2022 FY
2021 $5,304,509 +$1,655,182 +24% 01 Oct 2020 30 Sep 2021 10-K 13 Jan 2023 2022 FY
2020 $6,959,691 -$7,423,434 -1601% 01 Oct 2019 30 Sep 2020 10-K 13 Jan 2022 2021 FY
2019 $463,743 01 Oct 2018 30 Sep 2019 10-K 12 Jan 2021 2020 FY
2011 $218* 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.